Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; “Eve”) in healthy volunteers
- 15 December 1992
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 32 (12), 1108-1117
- https://doi.org/10.1016/0006-3223(92)90191-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sitesEuropean Journal of Pharmacology, 1988
- MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neuronsPharmacology Biochemistry and Behavior, 1988
- Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjectsBiological Psychiatry, 1987
- Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; “EVE”)Pharmacology Biochemistry and Behavior, 1987
- Subjective Reports of the Effects of MDMA in a Clinical SettingJournal of Psychoactive Drugs, 1986
- Designer Drug Confusion: A Focus on MDMAJournal of Drug Education, 1986
- Information on "Ecstasy"American Journal of Psychiatry, 1985
- Pimozide attentuates d-amphetamine-induced sleep changes in manLife Sciences, 1978
- Differential effects of D- and L-amphetamine on the sleep of depressed patientsLife Sciences, 1975
- Sleep Amphetamine Effects in MBDS and Normal SubjectsArchives of General Psychiatry, 1974